Pharmacologic magnetic resonance imaging (phMRI)

In Vivo MR Techniques in Drug Discovery and Development

Volumn , Issue , 2006, Pages 171-220

  Jenkins, Bruce G ^a   Choi, Ji Kyung ^a   Mandeville, Joseph B ^a   Chen, Yin Ching Iris ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65049091013     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (185)

1. Belliveau, J. W. et al., Functional mapping of the human visual cortex by magnetic resonance imaging, Science, 254, 716, 1991.
2. Kwong, K. K. et al., Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation, Proc. Natl. Acad. Sci. U.S.A, 89, 5675, 1992.
3. Ogawa, S. et al., Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging, Proc. Natl. Acad. Sci. U.S.A, 89, 5951, 1992.
4. Carlsson, C., Hagerdal, M., and Siesjo, B. K., Influence of amphetamine sulfate on cerebral blood flow and metabolism, Acta Physiol. Scand., 94, 128, 1975.
5. Chen, Y. I. et al., Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data, Magn. Reson. Med., 38, 389, 1997.
6. Silva, A. C. et al., Multislice MRI of rat brain during amphetamine stimulation using arterial spin labelling, Magn. Reson. Med., 33, 209, 1995.
7. Zhang, Z. et al., Pharmacological MRI mapping of age-associated changes in basal ganglia circuitry of awake rhesus monkeys, Neuroimage, 14, 1159, 2001.
8. Chen, Y. I. et al., Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioral assessment, Neuroreport, 10, 2881, 1999.
9. Febo, M. et al., The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats, Neuropsychopharmacology, 30, 936, 2005.
10. Marota, J. J. et al., Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat, Neuroimage, 11, 13, 2000.
11. 2 by multiple gradient recalled echo functional MRI, Magn. Reson. Imaging, 14, 469, 1996.
12. Nguyen, T. V. et al., Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET, Synapse, 36, 57, 2000.
13. Zhang, Z. et al., Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys, Brain Res., 852, 290, 2000.
14. Stein, E. A. et al., Nicotine-induced limbic cortical activation in the human brain: a functional MRI study, Am. J. Psychiatry, 155, 1009, 1998.
15. Xu, H. et al., Heroin-induced neuronal activation in rat brain assessed by functional MRI, Neuroreport, 11, 1085, 2000.
16. Scanley, B. E., Kennan, R. P., and Gore, J. C., Changes in rat cerebral blood volume due to modulation of the 5-HT(1A) receptor measured with susceptibility enhanced contrast MRI, Brain Res., 913, 149, 2001.
17. Honey, G. and Bullmore, E., Human pharmacological MRI, Trends Pharmacol. Sci., 25, 366, 2004.
18. Kimberg, D. Y. et al., Cortical effects of bromocriptine, a D-2 dopamine receptor agonist, in human subjects, revealed by fMRI, Hum. Brain Mapp., 12, 246, 2001.
19. Palacios, J. M. et al., Recent trends in receptor analysis techniques and instrumentation, J. Chem. Neuroanat., 4, 343, 1991.
20. Pompeiano, M., Palacios, J. M., and Mengod, G., Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding, J. Neurosci., 12, 440, 1992.
21. Schalling, M. et al., Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland, Eur. J. Pharmacol., 188, 277, 1990.
22. Knull, H. and Minton, A. P., Structure within eukaryotic cytoplasm and its relationship to glycolytic metabolism, Cell. Biochem. Funct., 14, 237, 1996.
23. Knull, H. R., Association of glycolytic enzymes with particulate fractions from nerve endings, Biochim. Biophys. Acta, 522, 1, 1978.
24. Knull, H. R. and Fillmore, S. J., Glycolytic enzyme levels in synaptosomes, Comp. Biochem. Physiol.[B], 81, 349, 1985.
25. Kadekaro, M., Crane, A. M., and Sokoloff, L., Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat, Proc. Natl. Acad. Sci. U.S.A, 82, 6010, 1985.
26. Sokoloff, L., Measurement of local cerebral glucose utilization and its relation to local functional activity in the brain, Adv. Exp. Med. Biol., 291, 21, 1991.
27. Sokoloff, L., Sites and mechanisms of function-related changes in energy metabolism in the nervous system, Dev. Neurosci., 15, 194, 1993.
28. Magistretti, P. J., Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling, Brain Res., 886, 108, 2000.
29. Pellerin, L. and Magistretti, P. J., Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization, Proc. Natl. Acad. Sci. U.S.A, 91, 10625, 1994.
30. Pellerin, L. and Magistretti, P. J., Excitatory amino acids stimulate aerobic glycolysis in astrocytes via an activation of the Na þ /K þ ATPase, Dev. Neurosci., 18, 336, 1996.
31. Sokoloff, L. et al., Contribution of astroglia to functionally activated energy metabolism, Dev. Neurosci., 18, 344, 1996.
32. Chih, C. P., Lipton, P., and Roberts, E. L. Jr., Do active cerebral neurons really use lactate rather than glucose?, Trends Neurosci., 24, 573, 2001.
33. Sorg, O. and Magistretti, P. J., Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes, Brain Res., 563, 227, 1991.
34. Stella, N. et al., Glutamate-evoked release of arachidonic acid from mouse brain astrocytes, J. Neurosci., 14, 568, 1994.
35. Cooper, J. R., Bloom, F. E., and Roth, R. H., The Biochemical Basis of Neuropharmacology, 7th ed., Oxford University Press, New York, 1996.
36. Lindvall, O., Ingvar, M., and Stenevi, U., Effects of methamphetamine on blood flow in the caudateputamen after lesions of the nigrostriatal dopaminergic bundle in the rat, Brain Res., 211, 211, 1981.
37. Lyons, D. and Porrino, L. J., Dopamine depletion in the rostral nucleus accumbens alters the cerebral metabolic response to cocaine in the rat, Brain Res., 753, 69, 1997.
38. Faraci, F. M. and Brian, J. E. Jr., Nitric oxide and the cerebral circulation, Stroke, 25, 692, 1994.
39. Fillenz, M. et al., The role of astrocytes and noradrenaline in neuronal glucose metabolism, Acta Physiol. Scand., 167, 275, 1999.
40. Iadecola, C., Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link?, Trends Neurosci., 16, 206, 1993.
41. Cohen, Z. et al., Serotonin in the regulation of brain microcirculation, Prog. Neurobiol., 50, 335, 1996.
42. Sato, A. and Sato, Y., Cholinergic neural regulation of regional cerebral blood flow, Alzheimer Dis. Assoc. Disord., 9, 28, 1995.
43. Vaucher, E., Linville, D., and Hamel, E., Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex, Neuroscience, 79, 827, 1997.
44. Elhusseiny, A. and Hamel, E., Muscarinic-but not nicotinic-acetylcholine receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: a possible role for the M5 receptor subtype, J. Cereb. Blood Flow Metab., 20, 298, 2000.
45. Barbelivien, A. et al., Neurochemical stimulation of the rat substantia innominata increases cerebral blood flow (but not glucose use) through the parallel activation of cholinergic and non-cholinergic pathways, Brain Res., 840, 115, 1999.
46. Head, R. J. et al., Isolated brain microvessels: preparation, morphology, histamine and catecholamine contents, Blood Vessels, 17, 173, 1980.
47. Jones, B. E., Relationship between catecholamine neurons and cerebral blood vessels studied by their simultaneous fluorescent revelation in the rat brainstem, Brain Res. Bull., 9, 33, 1982.
48. Krimer, L. S. et al., Dopaminergic regulation of cerebral cortical microcirculation, Nat. Neurosci., 1, 286, 1998.
49. Nehlig, A., Daval, J. L., and Debry, G., Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects, Brain Res. Brain Res. Rev., 17, 139, 1992.
50. Gulbenkian, S., Uddman, R., and Edvinsson, L., Neuronal messengers in the human cerebral circulation, Peptides, 22, 995, 2001.
51. Orzi, F. et al., Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat, J. Cereb. Blood Flow Metab., 3, 154, 1983.
52. Trugman, J. M. and James, C. L., D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation, Brain Res., 607, 270, 1993.
53. Wechsler, L. R., Savaki, H. E., and Sokoloff, L., Effects of d- and l-amphetamine on local cerebral glucose utilization in the conscious rat, J. Neurochem., 32, 15, 1979.
54. Jones, S. R. et al., Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter, J. Neurosci., 18, 1979, 1998.
55. Sulzer, D., Maidment, N. T., and Rayport, S., Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons, J. Neurochem., 60, 527, 1993.
56. Chen, Y. C. et al., Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging, Psychopharmacology (Berl), 2004, print ahead of time.
57. Ferre, S. et al., Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia, Neuroscience, 63, 765, 1994.
58. Latini, S. et al., A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system, Gen. Pharmacol., 27, 925, 1996.
59. Sebastiao, A. M. and Ribeiro, J. A., Adenosine A2 receptor-mediated excitatory actions on the nervous system, Prog. Neurobiol., 48, 167, 1996.
60. Quarta, D. et al., Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure, J. Neurochem., 88, 1151, 2004.
61. Chen, Y. I., Choi, J. K., and Jenkins, B. G., Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI, Synapse, 55, 80, 2004.
62. Ferre, S. et al., The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain, J. Neurosci., 13, 5402, 1993.
63. Villringer, A. et al., Dynamic imaging with lanthanidechelates in normal brain: contrast due to magnetic susceptibility effects, Magn. Reson. Med., 6, 164, 1988.
64. Frank, J. A. et al., Measurement of relative cerebral blood volume changes with visual stimulation by ‘double-dose’ gadopentetate-dimeglumine-enhanced dynamic magnetic resonance imaging, Invest. Radiol., 29 (Suppl. 2), S157, 1994.
65. Henriksen, L., Paulson, O. B., and Lassen, N. A., Visual cortex activation recorded by dynamic emission computed tomography of inhaled xenon 133, Eur. J. Nucl. Med., 6, 487, 1981.
66. Greenberg, J. H. et al., Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique, Science, 212, 678, 1981.
67. Mazziotta, J. C. et al., Tomographic mapping of human cerebral metabolism: auditory stimulation, Neurology, 32, 921, 1982.
68. Phelps, M. E., Positron computed tomography studies of cerebral glucose metabolism in man: theory and application in nuclear medicine, Semin. Nucl. Med., 11, 32, 1981.
69. Baron, J. C. et al., Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication, J. Nucl. Med., 23, 391, 1982.
70. Fox, P. T. et al., Nonoxidative glucose consumption during focal physiologic neural activity, Science, 241, 462, 1988.
71. Grafton, S. T., PET: activation of cerebral blood flow and glucose metabolism, Adv. Neurol., 83, 87, 2000.
72. Lassen, N. A. and Ingvar, D. H., Brain regions involved in voluntary movements as revealed by radioisotopic mapping of CBF or CMR-glucose changes, Rev. Neurol. (Paris), 146, 620, 1990.
73. Singer, J. R., Science, 130, 1652, 1959.
74. Dixon, W. T. et al., Projection angiograms of blood labeled by adiabatic fast passage, Magn. Reson. Med., 3, 454, 1986.
75. Detre, J. A. et al., Perfusion imaging, Magn. Reson. Med., 23, 37, 1992.
76. Ogawa, S. et al., Brain magnetic resonance imaging with contrast dependent on blood oxygenation, Proc. Natl. Acad. Sci. U.S.A, 87, 9868, 1990.
77. Turner, R. et al., Echo-planar time course MRI of cat brain oxygenation changes, Magn. Reson. Med., 22, 159, 1991.
78. Bandettini, P. A. et al., Time course EPI of human brain function during task activation, Magn. Reson. Med., 25, 390, 1992.
79. Davis, T. L. et al., Calibrated functional MRI: mapping the dynamics of oxidative metabolism, Proc. Natl. Acad. Sci. U.S.A, 95, 1834, 1998.
80. Hoge, R. D. et al., Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model, Magn. Reson. Med., 42, 849, 1999.
81. Mandeville, J. B. et al., MRI measurement of the temporal evolution of relative CMRO(2) during rat forepaw stimulation, Magn. Reson. Med., 42, 944, 1999.
82. Ogawa, S., Lee, R. M., and Barrere, B., The sensitivity of magnetic resonance image signals of a rat brain to changes in the cerebral venous blood oxygenation, Magn. Reson. Med., 29, 205, 1993.
83. Fox, P. T. and Raichle, M. E., Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects, Proc. Natl. Acad. Sci. U.S.A, 83, 1140, 1986.
84. Hyder, F. et al., Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with 1H[13C]NMR, Proc. Natl. Acad. Sci. U.S.A, 93, 7612, 1996.
85. Hyder, F. et al., Oxidative glucose metabolism in rat brain during single forepaw stimulation: a spatially localized 1H[13C] nuclear magnetic resonance study, J. Cereb. Blood Flow Metab., 17, 1040, 1997.
86. Chen, W. et al., Study of tricarboxylic acid cycle flux changes in human visual cortex during hemifield visual stimulation using (1)H-[(13)C] MRS and fMRI, Magn. Reson. Med., 45, 349, 2001.
87. Chen, Y. C. et al., Improved mapping of pharmacologically induced neuronal activation using the IRON technique with superparamagnetic blood pool agents, J. Magn. Reson. Imaging, 14, 517, 2001.
88. Kennan, R. P. et al., Physiological basis for BOLD MR signal changes due to neuronal stimulation: separation of blood volume and magnetic susceptibility effects, Magn. Reson. Med., 40, 840, 1998.
89. Mandeville, J. B. et al., Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation, Magn. Reson. Med., 39, 615, 1998.
90. van Bruggen, N. et al., High-resolution functional magnetic resonance imaging of the rat brain: mapping changes in cerebral blood volume using iron oxide contrast media, J. Cereb. Blood Flow Metab., 18, 1178, 1998.
91. Mandeville, J. B. et al., Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain, Magn. Reson. Med., 45, 443, 2001.
92. Taylor, A. M. et al., Use of the intravascular contrast agent NC100150 injection in spin-echo and gradient-echo imaging of the heart, J. Cardiovasc. Magn. Reson., 1, 23, 1999.
93. Saini, S. et al., Multicentre dose-ranging study on the efficacy of USPIO ferumoxtran-10 for liver MR imaging, Clin. Radiol., 55, 690, 2000.
94. Mandeville, J. B. et al., Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T, Magn. Reson. Med., 52, 1272, 2004.
95. Prichard, J. et al., Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation, Proc. Natl. Acad. Sci. U.S.A, 88, 5829, 1991.
96. Chhina, N. et al., Measurement of human tricarboxylic acid cycle rates during visual activation by (13)C magnetic resonance spectroscopy, J. Neurosci. Res., 66, 737, 2001.
97. Merboldt, K. D. et al., Decrease of glucose in the human visual cortex during photic stimulation, Magn. Reson. Med., 25, 187, 1992.
98. Gruetter, R. et al., Observation of resolved glucose signals in 1H NMR spectra of the human brain at 4 Tesla, Magn. Reson. Med., 36, 1, 1996.
99. Gruetter, R., Seaquist, E. R., and Ugurbil, K., A mathematical model of compartmentalized neurotransmitter metabolism in the human brain, Am. J. Physiol. Endocrinol. Metab., 281, E100, 2001.
100. Mason, G. F. et al., Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR, J. Cereb. Blood Flow Metab., 15, 12, 1995.
101. Guimaraes, A. R. et al., Echoplanar chemical shift imaging, Magn. Reson. Med., 41, 877, 1999.
102. Hyder, F., Renken, R., and Rothman, D. L., In vivo carbon-edited detection with proton echo-planar spectroscopic imaging (ICED PEPSI): [3,4-(13)CH(2)]glutamate/glutamine tomography in rat brain, Magn. Reson. Med., 42, 997, 1999.
103. Posse, S. et al., In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging (PEPSI), Magn. Reson. Med., 37, 858, 1997.
104. Loubinoux, I. et al., Cerebral metabolic changes induced by MK-801: a 1D (phosphorus and proton) and 2D (proton) in vivo NMR spectroscopy study, Brain Res., 643, 115, 1994.
105. Petroff, O. A. and Rothman, D. L., Measuring human brain GABA in vivo: effects of GABAtransaminase inhibition with vigabatrin, Mol. Neurobiol., 16, 97, 1998.
106. Kustermann, E. H. G. et al., Assessment of amphetamine induced stimulus using in vivo 13C MRS in rat brain, International Society for Magnetic Resonance in Medicine, Sydney, Australia, p. 1362, 1998.
107. 1 -weighted MRI during brain activation: an approach to direct imaging of brain function, Magn. Reson. Med., 38, 378, 1997.
108. Duong, T. Q. et al., Functional MRI of calcium-dependent synaptic activity: cross correlation with CBF and BOLD measurements, Magn. Reson. Med., 43, 383, 2000.
109. Verity, M. A., Manganese neurotoxicity: a mechanistic hypothesis, Neurotoxicology, 20, 489, 1999.
110. Watanabe, T., Frahm, J., and Michaelis, T., Functional mapping of neural pathways in rodent brain in vivo using manganese-enhanced three-dimensional magnetic resonance imaging, NMR Biomed., 17, 554, 2004.
111. Weckesser, M. et al., Functional imaging of the visual cortex with bold-contrast MRI: hyperventilation decreases signal response, Magn. Reson. Med., 41, 213, 1999.
112. Gollub, R. L. et al., Cocaine decreases cortical cerebral blood flow but does not obscure regional activation in functional magnetic resonance imaging in human subjects, J. Cereb. Blood Flow Metab., 18, 724, 1998.
113. Zaharchuk, G. et al., Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension, Stroke, 30, 2197, 1999.
114. Kalisch, R. et al., Blood pressure changes induced by arterial blood withdrawal influence bold signal in anesthesized rats at 7 Tesla: implications for pharmacologic MRI, Neuroimage, 14, 891, 2001.
115. Longnecker, D. E. and Harris, P. D., Microcirculatory actions of general anesthetics, Fed. Proc., 39, 1580, 1980.
116. Stullken, E. H. Jr. et al., The nonlinear responses of cerebral metabolism to low concentrations of halothane, enflurane, isoflurane, and thiopental, Anesthesiology, 46, 28, 1977.
117. Lindauer, U., Villringer, A., and Dirnagl, U., Characterization of CBF response to somatosensory stimulation: model and influence of anesthetics, Am. J. Physiol., 264, H1223, 1993.
118. Hara, K. and Harris, R. A., The anesthetic mechanism of urethane: the effects on neurotransmittergated ion channels, Anesth. Analg., 94, 313, 2002.
119. Anis, N. A. et al., The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate, Br. J. Pharmacol., 79, 565, 1983.
120. Thomson, A. M., West, D. C., and Lodge, D., An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?, Nature, 313, 479, 1985.
121. Hancock, P. J. and Stamford, J. A., Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens, Br. J. Anaesth., 82, 603, 1999.
122. Ueki, M., Mies, G., and Hossmann, K. A., Effect of alpha-chloralose, halothane, pentobarbital and nitrous oxide anesthesia on metabolic coupling in somatosensory cortex of rat, Acta Anaesthesiol. Scand., 36, 318, 1992.
123. Nieoullon, A. and Dusticier, N., Effects of alpha-chloralose on the activity of the nigrostriatal dopaminergic system in the cat, Eur. J. Pharmacol., 65, 403, 1980.
124. Chen, Y. I., et al., Anesthetic filters for eliciting specific neurotransmitter effects in pharmacologic MRI, Proceedings of the eighth annual meeting International Society of Magnetic Resonance in Medicine, Denver, CO, p. 967, 2000.
125. Maekawa, T. et al., Local cerebral blood flow and glucose utilization during isoflurane anesthesia in the rat, Anesthesiology, 65, 144, 1986.
126. Lahti, K. M. et al., Comparison of evoked cortical activity in conscious and propofol-anesthetized rats using functional MRI, Magn. Reson. Med., 41, 412, 1999.
127. Peeters, R. R. et al., Comparing BOLD fMRI signal changes in the awake and anesthetized rat during electrical forepaw stimulation, Magn. Reson. Imaging, 19, 821, 2001.
128. Dubowitz, D. J. et al., Functional magnetic resonance imaging in macaque cortex, Neuroreport, 9, 2213, 1998.
129. Leite, F. P. et al., Repeated fMRI using iron oxide contrast agent in awake, behaving macaques at 3 Tesla, Neuroimage, 16, 283, 2002.
130. Stefanacci, L. et al., fMRI of monkey visual cortex, Neuron, 20, 1051, 1998.
131. Vanduffel, W. et al., Visual motion processing investigated using contrast agent-enhanced fMRI in awake behaving monkeys, Neuron, 32, 565, 2001.
132. Schwarz, A. et al., Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain, Synapse, 54, 1, 2004.
133. Kleven, M. S. et al., Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain, Brain Res., 532, 265, 1990.
134. Letchworth, S. R. et al., Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat, Brain Res., 750, 214, 1997.
135. Bloom, A. S. et al., Determination of drug-induced changes in functional MRI signal using a pharmacokinetic model, Hum. Brain Mapp., 8, 235, 1999.
136. Wise, R. G. et al., Combining fMRI with a pharmacokinetic model to determine which brain areas activated by painful stimulation are specifically modulated by remifentanil, Neuroimage, 16, 999, 2002.
137. Wise, R. G., Williams, P., and Tracey, I., Using fMRI to quantify the time dependence of remifentanil analgesia in the human brain, Neuropsychopharmacology, 29, 626, 2004.
138. Mulder, A. H. et al., Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release, Nature, 308, 278, 1984.
139. Madras, B. K. et al., Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4- fluorophenyl)tropane, Mol. Pharmacol., 36, 518, 1989.
140. Endres, C. J. et al., Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies, J. Cereb. Blood Flow Metab., 17, 932, 1997.
141. Berntman, L. et al., Circulatory and metabolic effects in the brain induced by amphetamine sulphate, Acta Physiol. Scand., 102, 310, 1978.
142. Perese, D. A. et al., A 6-hydroxydopamine-induced selective parkinsonian rat model, Brain Res., 494, 285, 1989.
143. Bjorklund, L. M. et al., Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model, Proc. Natl. Acad. Sci. U.S.A, 99, 2344, 2002.
144. Beauregard, M., Levesque, J., and Bourgouin, P., Neural correlates of conscious self-regulation of emotion, J. Neurosci., 21, RC165, 2001.
145. Koepp, M. J. et al., Evidence for striatal dopamine release during a video game, Nature, 393, 266, 1998.
146. Blood, A. J. and Zatorre, R. J., Intensely pleasurable responses to music correlate with activity in brain regions implicated in reward and emotion, Proc. Natl. Acad. Sci. U.S.A, 98, 11818, 2001.
147. Loubinoux, I. et al., Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks, J. Cereb. Blood Flow Metab., 19, 1365, 1999.
148. Sell, L. A. et al., Functional magnetic resonance imaging of the acute effect of intravenous heroin administration on visual activation in long-term heroin addicts: results from a feasibility study, Drug Alcohol Depend., 49, 55, 1997.
149. Uftring, S. J. et al., An fMRI study of the effect of amphetamine on brain activity, Neuropsychopharmacology, 25, 925, 2001.
150. Breiter, H. C. et al., Functional imaging of neural responses to expectancy and experience of monetary gains and losses, Neuron, 30, 619, 2001.
151. Breiter, H. C. and Rosen, B. R., Functional magnetic resonance imaging of brain reward circuitry in the human, Ann. NY Acad. Sci., 877, 523, 1999.
152. Chen, Y. I. et al., Improved mapping of pharmacologically induced neuronal activation using superparamagnetic iron blood pool agents, International Society of Magnetic Resonance Medicine Seventh Annual Meeting, Philadelphia, PA, p. 348, 1999.
153. Kaufman, M. J. et al., Cocaine-induced cerebral vasoconstriction differs as a function of sex and menstrual cycle phase, Biol. Psychiatry, 49, 774, 2001.
154. Breiter, H. C. et al., Acute effects of cocaine on human brain activity and emotion, Neuron, 19, 591, 1997.
155. Risinger, R. C. et al., Neural correlates of high and craving during cocaine self-administration using BOLD fMRI, Neuroimage, 26, 1097, 2005.
156. Garavan, H. et al., Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli, Am. J. Psychiatry, 157, 1789, 2000.
157. Maas, L. C. et al., Functional magnetic resonance imaging of human brain activation during cueinduced cocaine craving, Am. J. Psychiatry, 155, 124, 1998.
158. Morgan, D. et al., Social dominance in monkeys: dopamine D2 receptors and cocaine selfadministration, Nat. Neurosci., 5, 169, 2002.
159. Volkow, N. D. and Fowler, J. S., Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex, Cereb. Cortex, 10, 318, 2000.
160. Nestler, E. J., Molecular neurobiology of addiction, Am. J. Addict., 10, 201, 2001.
161. Elman, I. et al., Clinical outcomes following cocaine infusion in nontreatment-seeking individuals with cocaine dependence, Biol. Psychiatry, 49, 553, 2001.
162. Bradberry, C. W. et al., Impact of self-administered cocaine and cocaine cues on extracellular dopamine in mesolimbic and sensorimotor striatum in rhesus monkeys, J. Neurosci., 20, 3874, 2000.
163. Nyback, H. et al., Attempts to visualize nicotinic receptors in the brain of monkey and man by positron emission tomography, Prog. Brain Res., 79, 313, 1989.
164. Domino, E. F. et al., Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers, Synapse, 38, 313, 2000.
165. Zubieta, J. et al., Regional cerebral blood flow effects of nicotine in overnight abstinent smokers, Biol. Psychiatry, 49, 906, 2001.
166. Sell, L. A. et al., Neural responses associated with cue evoked emotional states and heroin in opiate addicts, Drug Alcohol Depend., 60, 207, 2000.
167. Fuller, S. A. and Stein, E. A., Effects of heroin and naloxone on cerebral blood flow in the conscious rat, Pharmacol. Biochem. Behav., 40, 339, 1991.
168. Trusk, T. C. and Stein, E. A., Effect of intravenous heroin and naloxone on regional cerebral blood flow in the conscious rat, Brain Res., 406, 238, 1987.
169. Xi, Z. X. et al., Opiate tolerance by heroin self-administration: an fMRI study in rat, Magn. Reson. Med., 52, 108, 2004.
170. Robinson, T. E., Castaneda, E., and Whishaw, I. Q., Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methampehtamine: a review of evidence from microdialysis studies, Can. J. Psychol., 44, 253, 1990.
171. Singer, T. P. and Ramsay, R. R., Mechanism of the neurotoxicity of MPTP. An update, FEBS Lett., 274, 1, 1990.
172. Jenkins, B. G. et al., Mapping dopamine function in primates using pharmacologic magnetic resonance imaging, J. Neurosci., 24, 9553, 2004.
173. Brownell, A.-L. et al., Cocaine congeners as PET imaging probes for dopamine terminals in normal and MPTP induced parkinsonism in nonhuman primate brain, J. Nucl. Med., 37, 1186, 1996.
174. Albrecht, R. F. et al., Cerebral blood flow and metabolic changes from induction to onset of anesthesia with halothane or pentobarbital, Anesthesiology, 47, 252, 1977.
175. Cavazzuti, M. et al., Ketamine effects on local cerebral blood flow and metabolism in the rat, J. Cereb. Blood Flow Metab., 7, 806, 1987.
176. Hougaard, K., Hansen, A., and Brodersen, P., The effect of ketamine on regional cerebral blood flow in man, Anesthesiology, 41, 562, 1974.
177. Takeshita, H., Okuda, Y., and Sari, A., The effects of ketamine on cerebral circulation and metabolism in man, Anesthesiology, 36, 69, 1972.
178. 2 reactivity of brain vessels in the human, Anaesthesist, 36, 60, 1987.
179. Vandesteene, A. et al., Effect of propofol on cerebral blood flow and metabolism in man, Anaesthesia, (Suppl. 43), 42, 1988.
180. Algotsson, L. et al., Cerebral blood flow and oxygen consumption during isoflurane and halothane anesthesia in man, Acta Anaesthesiol. Scand., 32, 15, 1988.
181. Drummond, J. C. et al., A comparison of the direct cerebral vasodilating potencies of halothane and isoflurane in the New Zealand white rabbit, Anesthesiology, 65, 462, 1986.
182. Todd, M. M. and Drummond, J. C., A comparison of the cerebrovascular and metabolic effects of halothane and isoflurane in the cat, Anesthesiology, 60, 276, 1984.
183. Cucchiara, R. F., Theye, R. A., and Michenfelder, J. D., The effects of isoflurane on canine cerebral metabolism and blood flow, Anesthesiology, 40, 571, 1974.
184. Hansen, T. D. et al., The role of cerebral metabolism in determining the local cerebral blood flow effects of volatile anesthetics: evidence for persistent flow-metabolism coupling, J. Cereb. Blood Flow Metab., 9, 323, 1989.
185. Schmahl, F. W., Effects of anesthetics on regional cerebral blood flow and the regional content of some metabolites of the brain cortex of the cat, Acta Neurol. Scand., (Suppl. 14), 156, 1965.